| Primary |
| Colorectal Cancer Metastatic |
33.5% |
| Colorectal Cancer |
16.7% |
| Gastric Cancer |
7.0% |
| Colon Cancer |
6.6% |
| Rectal Cancer |
3.7% |
| Hypertension |
3.7% |
| Colon Cancer Metastatic |
3.2% |
| Prophylaxis |
3.1% |
| Glioblastoma Multiforme |
3.1% |
| Small Cell Lung Cancer Stage Unspecified |
3.0% |
| Premedication |
2.7% |
| Pain |
2.5% |
| Nausea |
1.8% |
| Glioblastoma |
1.8% |
| Metastatic Gastric Cancer |
1.5% |
| Diarrhoea |
1.4% |
| Prophylaxis Of Nausea And Vomiting |
1.4% |
| Pancreatic Carcinoma |
1.2% |
| Constipation |
1.0% |
| Metastatic Colorectal Cancer |
1.0% |
|
| Vomiting |
15.9% |
| Thrombocytopenia |
10.5% |
| Death |
9.7% |
| Neutropenia |
6.5% |
| Pulmonary Embolism |
6.2% |
| Pyrexia |
5.7% |
| Sepsis |
5.3% |
| Diarrhoea |
4.8% |
| General Physical Health Deterioration |
4.8% |
| Respiratory Failure |
3.5% |
| Pneumonia |
3.3% |
| Hypokalaemia |
3.0% |
| Leukopenia |
2.8% |
| Neuropathy Peripheral |
2.8% |
| Interstitial Lung Disease |
2.7% |
| Renal Failure Acute |
2.7% |
| Dysarthria |
2.5% |
| Neoplasm Malignant |
2.5% |
| Septic Shock |
2.5% |
| Disease Progression |
2.2% |
|
| Secondary |
| Colorectal Cancer |
22.5% |
| Colorectal Cancer Metastatic |
21.8% |
| Drug Use For Unknown Indication |
10.4% |
| Colon Cancer |
7.3% |
| Rectal Cancer |
4.3% |
| Premedication |
4.3% |
| Gastric Cancer |
4.2% |
| Colon Cancer Metastatic |
3.8% |
| Prophylaxis |
3.0% |
| Glioblastoma Multiforme |
2.5% |
| Glioblastoma |
2.5% |
| Hypertension |
2.2% |
| Neoplasm |
1.8% |
| Nausea |
1.6% |
| Diarrhoea |
1.4% |
| Pain |
1.4% |
| Antiemetic Supportive Care |
1.3% |
| Small Cell Lung Cancer Stage Unspecified |
1.3% |
| Oesophageal Carcinoma |
1.3% |
| Metastatic Gastric Cancer |
1.2% |
|
| Vomiting |
15.7% |
| Pyrexia |
6.9% |
| Diarrhoea |
6.8% |
| Thrombocytopenia |
6.7% |
| Neutropenia |
6.5% |
| Pulmonary Embolism |
5.9% |
| White Blood Cell Count Decreased |
5.9% |
| Febrile Neutropenia |
5.1% |
| Sepsis |
4.7% |
| Interstitial Lung Disease |
4.6% |
| Death |
4.4% |
| Intestinal Obstruction |
4.1% |
| General Physical Health Deterioration |
3.3% |
| Ileus |
3.2% |
| Nausea |
3.0% |
| Pneumonia |
2.9% |
| Small Intestinal Obstruction |
2.8% |
| Decreased Appetite |
2.6% |
| Renal Failure Acute |
2.5% |
| Stomatitis |
2.5% |
|
| Concomitant |
| Colorectal Cancer |
20.3% |
| Drug Use For Unknown Indication |
19.0% |
| Colorectal Cancer Metastatic |
10.9% |
| Colon Cancer |
10.6% |
| Premedication |
9.0% |
| Colon Cancer Metastatic |
7.0% |
| Rectal Cancer |
5.8% |
| Prophylaxis |
3.0% |
| Antiemetic Supportive Care |
1.9% |
| Large Intestine Carcinoma |
1.7% |
| Rectal Cancer Metastatic |
1.6% |
| Glioblastoma Multiforme |
1.5% |
| Hypertension |
1.4% |
| Chemotherapy |
1.1% |
| Pain |
1.1% |
| Product Used For Unknown Indication |
1.1% |
| Colon Cancer Recurrent |
0.8% |
| Nausea |
0.8% |
| Rectal Cancer Recurrent |
0.8% |
| Cancer Pain |
0.8% |
|
| Vomiting |
12.1% |
| Pulmonary Embolism |
7.9% |
| Rash |
7.5% |
| Death |
6.5% |
| Pyrexia |
6.5% |
| Sepsis |
5.7% |
| Disease Progression |
5.5% |
| Dermatitis Acneiform |
5.3% |
| White Blood Cell Count Decreased |
5.3% |
| Neutropenia |
3.8% |
| Thrombosis |
3.8% |
| Diarrhoea |
3.6% |
| Interstitial Lung Disease |
3.6% |
| Thrombocytopenia |
3.6% |
| Intestinal Obstruction |
3.4% |
| Malignant Neoplasm Progression |
3.4% |
| Stomatitis |
3.4% |
| Renal Impairment |
3.2% |
| Mucosal Inflammation |
3.0% |
| Infusion Related Reaction |
2.8% |
|
| Interacting |
| Prophylaxis Of Nausea And Vomiting |
16.2% |
| Cholinergic Syndrome |
13.5% |
| Gallbladder Cancer |
13.5% |
| Adult T-cell Lymphoma/leukaemia |
8.1% |
| Convulsion |
8.1% |
| Colon Cancer Metastatic |
5.4% |
| Colorectal Cancer Metastatic |
5.4% |
| Epilepsy |
5.4% |
| Oesophageal Carcinoma |
5.4% |
| Chemotherapy |
2.7% |
| Fungal Infection |
2.7% |
| Hyperlipidaemia |
2.7% |
| Hypertension |
2.7% |
| Malignant Ascites |
2.7% |
| Myocardial Ischaemia |
2.7% |
| Type 2 Diabetes Mellitus |
2.7% |
|
| Drug Interaction |
25.0% |
| Hepatotoxicity |
25.0% |
| Epilepsy |
16.7% |
| Neutropenia |
16.7% |
| Myalgia |
8.3% |
| Somnolence |
8.3% |
|
